Arkolith/Insider Trading/VIR/Form 4

SB Investment Advisers (UK) Ltd

10% OwnerVir Biotechnology, Inc. (VIR) · full profile →Form 4 · filed Oct 24, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.8M
Net Open-Market Flow
-$1.8M
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 23, 2025Sell(S)154K$5.99$925K14.7M
Oct 22, 2025Sell(S)144K$6.15$887K14.9M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-25-019309) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML